BioGaia Gastrus Pure Action
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Limosilactobacillus Reuteri Source : DSM 17938 | 100 Millions d'UFC | Not calculated |
| Limosilactobacillus reuteri Source : ATCC PTA 6475 | 100 Millions d'UFC | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Cellulose microcristalline, Stéarate de calcium, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps reduce symptoms associated with irritable bowel syndrome (IBS). Helps relieve symptoms associated with irritable bowel syndrome (IBS). Helps relieve and manage symptoms associated with irritable bowel syndrome (IBS). Helps reduce abdominal pain, discomfort, gas, and bloating significantly in healthy adults. Helps reduce abdominal pain, discomfort, gas, and bloating in healthy adults. Helps promote bowel movements/regularity in adults with functional constipation. Helps reduce gastrointestinal antibiotic-associated side-effects. Helps reduces side-effects during triple therapy for H. pylori infection. Helps reduce in abdominal pain significantly in healthy adults. Helps to reduce abdominal pain in healthy adults. Helps with occasional gastrointestinal discomfort, gas and bloating.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- BioGaia Probiotics Canada Inc.
- NPN or DIN-HM
- 80139691
- Status
- Active licence
- Licence date
- 31 March 2025
- Revision date
- 5 January 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80139691
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BioGaia Gastrus Pure Action (BioGaia Probiotics Canada Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80139691-biogaia-gastrus-pure-action, updated 5 January 2026.